Logo.png
R&D Employees' Top Challenge Is Lack of Access to Existing Knowledge and Expertise, Coveo Digital Poll Reveals
20 juin 2012 08h40 HE | Coveo
QUEBEC--(Marketwire - Jun 20, 2012) - According to a digital poll conducted by Coveo, the unnecessary replication of pre-existing work is the biggest productivity...
TuftsCSDD-Logo-Color.jpg
Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
09 mai 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 9, 2012) - Drug sponsors experienced a mixed regulatory burden under the FDA Amendments Act, which was also the fourth iteration of the Prescription Drug User Fee Act...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
26 avr. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Apr 26, 2012) - Drug companies looking to increase the efficiency and productivity of their R&D pipelines are turning to a host of techniques and approaches aimed at...
TuftsCSDD-Logo-Color.jpg
Drugs to Treat CNS Diseases Take 35% Longer to Develop Than Other Drugs, According to Tufts Center for the Study of Drug Development
06 mars 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Mar 6, 2012) - Drugs developed to treat central nervous system (CNS) diseases take 35% longer to complete clinical trials and receive regulatory approval compared to other...
ricoh-tours-logo.png
Ricoh Innovations Expands R&D Into India
14 févr. 2012 22h00 HE | Ricoh Innovations, Inc.
MENLO PARK, CA--(Marketwire - Feb 14, 2012) - Ricoh Innovations, Inc. ("RII"), a Silicon Valley-based subsidiary of Ricoh Company, Ltd., which develops innovative technologies and new business...
TuftsCSDD-Logo-Color.jpg
Drug Company Executives Are Expanding Their Use of Strategic Partnerships, According to Tufts Center for the Study of Drug Development
26 janv. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 26, 2012) - Pharmaceutical and biopharmaceutical companies, under pressure to increase R&D productivity, are expanding their use of strategic partnerships to bring...
Today's Key Leadership Challenge: Making Innovation Everyone's Mandate
11 janv. 2012 11h15 HE | Innosight
BOSTON, MA--(Marketwire - Jan 11, 2012) - Innovation mastery remains elusive, despite decades of superb thinking and work on the topic. Too often, companies mistake creativity for innovation,...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Taking Steps to Improve R&D Productivity, According to Tufts Center for the Study of Drug Development
05 janv. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 5, 2012) - Although drug companies are pursuing innovative approaches to increase the pace and reduce the cost of drug development, the greatest advances will come...
Battelle-R&D Magazine Annual Global Funding Forecast Predicts R&D Spending Growth Will Continue While Globalization Accelerates
16 déc. 2011 12h13 HE | Battelle
COLUMBUS, OH--(Marketwire - Dec 16, 2011) - The Battelle-R&D Magazine annual Global R&D Funding Forecast released today shows global research and development (R&D) spending is expected...
TuftsCSDD-Logo-Color.jpg
Number of Monoclonal Antibody Products in Development Continues to Increase, According to Tufts Center for the Study of Drug Development
08 nov. 2011 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Nov 8, 2011) - Developers are steadily increasing the number of monoclonal antibody products -- known as mAbs -- for which they are initiating clinical studies, extending...